Elevated serum levels of IFN-γ, IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage

Journal of Neuroimmunology

Volumn 87, Issue 1-2, 1998, Pages 27-32

  Hohnoki, Kiyoto ^a   Inoue, Atsushi ^b   Koh, Chang Sung ^b  

^a Higashinagano National Hospital   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Demyelinating disease; IFN ; IL 10; IL 4; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; FEMALE; GUILLAIN BARRE SYNDROME; HELPER CELL; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SUBCLAVIAN STEAL SYNDROME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DEMYELINATING DISEASES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; MULTIPLE SCLEROSIS; POLYRADICULONEUROPATHY; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032126914     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00053-8     Document Type: Article

References (52)

1. Ando, D.G., Clayton, J., Kono, D., Urban, J.L., Sercarz, E.E., 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th1 lymphokine subtype. Cell. Immunol. 124, 132-143.
2. Asbury, A.K., Cornblath, D.R., 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27, S21-S24, Suppl.
3. Asbury, A.K., Arnason, B.G.W., Karp, H.R., McFarlin, D.E., 1978. Criteria for diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3, 565-566.
4. Bai, X.-F., Zhu, J., Zhang, G.-X., Kaponides, G., Höjeberg, B., van der Meide, P.H., Link, H., 1997. IL-10 suppresses experimental autoimmune neuritis and down-regulates Th1-type immune responses. Clin. Immunol. Immunopathol. 83, 117-126.
5. Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H., Wietzerbin, J., 1988. Increased production of interferon-γ and tumor necrosis factor proceeds clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?. Acta Neurol. Scand. 78, 318-323.
6. Benvenuto, R., Paroli, M., Buttinelli, C., Franco, A., Barnaba, V., Fieschi, C., Balsano, F., 1991. Tumor necrosis factor-α synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis. Clin. Exp. Immunol. 84, 97-102.
7. + T cell IL-10 production in stable relapsing multiple sclerosis. Int. J. Neurosci. 90, 187-202.
8. Cannella, B., Raine, C.S., 1995. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435.
9. Crucian, B., Dunne, P., Friedman, H., Ragsdale, R., Pross, S., Widen, R., 1995. Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients. Clin. Diagn. Lab. Immunol. 2, 766-769.
10. Dahle, C., Vrethem, M., Ernerudh, J., 1994. T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barré syndrome. J. Neuroimmunol. 53, 219-225.
11. D'Andrea, A., Aste-Amezaga, M., Valiante, N.M., Ma, X., Kubin, M., Trinchieri, G., 1993. Interleukin-10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048.
12. Del Prete, G.F., De Carli, M., Mastromauro, C., Biagiotti, R., Macchia, D., Falagiani, P., Ricci, M., Romagnani, S., 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88, 346-350.
13. Fiorentino, D.F., Bond, M.W., Mosmann, T.R., 1989. Tow types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095.
14. Fisher, M., 1956. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia, and areflexia). New Engl. J. Med. 255, 57-65.
15. Franciotta, D.M., Grimaldi, L.M.E., Martino, G.V., Piccolo, G., Bergamaschi, R., Citterio, A., Melzi d'Eril, G.V., 1989. Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 26, 787-789.
16. Gajewski, T.F., Fitch, F.W., 1988. Anti-proliferative effect of IFN-γ in immune regulation: I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140, 4245-4252.
17. Gallo, P., Piccinno, M.G., Tavolato, B., Sidén, Å., 1991. A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum. J. Neurol. Sci. 101, 227-232.
18. Griffin, J.W., Macko, C., Li, C.Y., Ramos-Alvarez, M., Ho, T., Asbury, A.K., 1994. New perspectives on the pathology of Guillain-Barré syndrome. Muscle Nerve Suppl. S73.
19. Hemmer, B., Vergelli, M., Calabresi, P., Huang, T., McFarland, H.F., Martin, R., 1996. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99). J. Neurosci. Res. 45, 852-862.
20. Inoue, A., Iwahashi, T., Koh, C.-S., Yanagisawa, N., 1994. A study on subpopulation of helper T cells in chronic inflammatory demyelinating polyneuropathy. Jpn. J. Allergol. 43, 1270-1276.
21. Kennedy, M.K., Torrance, D.S., Picha, K.S., Mohler, K.M., 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149, 2496-2505.
22. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38.
23. Link, J., Söderström, M., Olsson, T., Höjeberg, B., Ljungdahl, Å., Link, H., 1994a. Increased transforming growth factor-β, interleukin-4 and interferon-γ in multiple sclerosis. Ann. Neurol. 36, 379-386.
24. Link, J., Söderström, M., Ljungdahl, Å., Höjeberg, B., Olsson, T., Xu, Z., Fredrikson, S., Wang, Z.-Y., Link, H., 1994b. Organ-specific autoantigens induce interferon-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 44, 728-734.
25. Lu, C.-Z., Jensen, M.A., Arnason, B.G.W., 1993. Interferon γ- and interleukin-4-secreting cells in multiple sclerosis. J. Neuroimmunol. 46, 123-128.
26. Mosmann, T.R., Sad, S., 1996. The expanding universe of T cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
27. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., Coffman, R.L., 1986. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
28. Navikas, V., Link, J., Palasik, W., Söderstöm, M., Fredrikson, S., Olsson, T., Link, H., 1995. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand. J. Immunol. 41, 171-178.
29. Navikas, V., He, B., Link, J., Haglund, M., Söderström, M., Fredrikson, S., Ljungdahl, Å., Höjeberg, J., Qiao, J., Olsson, T., Link, H., 1996. Augmented expression of tumor necrosis factor-α and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 119, 213-223.
30. Olsson, T., 1992. Immunology of multiple sclerosis. Curr. Opin. Neurol. Nuerosurg. 5, 195-202.
31. Olsson, T., Zhi, W.W., Höjeberg, B., Kostulas, V., Yu-Ping, J., Anderson, G., Ekre, H.-P., Link, H., 1990a. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J. Clin. Invest. 86, 981-985.
32. Olsson, T., Baig, S., Höjeberg, B., Link, H., 1990b. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann. Neurol. 27, 132-136.
33. Paul, N.L., Ruddle, N.H., 1988. Lymphotoxin. Annu. Rev. Immunol. 6, 407-438.
34. Paul, W.E., Seder, R.A., 1994. Lymphocyte responses and cytokines. Cell 76, 241-251.
35. Pober, J.S., Lapierre, L.A., Stolpen, A.H., Brock, T.A., Springer, T.A., Fiers, W., Bevilacqua, M.P., Mendrick, D.L., Gimbrone, M.A. Jr., 1987. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin-1 species. J. Immunol. 138, 3319-3324.
36. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H., Tourtellotte, W.W., 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
37. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M., Röcken, M., 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961-1966.
38. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., Poser, S., 1994. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44, 1523-1526.
39. Röcken, M., Racke, M., Shevach, E.M., 1996. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 17, 225-231.
40. Rott, O., Fleischer, B., Cash, E., 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24, 1434-1440.
41. Selmaj, K.W., Raine, C.S., 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
42. Selmaj, K., Raine, C.S., Cross, A.H., 1991a. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30, 694-700.
43. Selmaj, K., Raine, C.S., Cannella, B., Brosnan, C.F., 1991b. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
44. Sharief, M.K., Hentges, R., 1991. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. New Engl. J. Med. 325, 467-472.
45. Sharief, M.K., McLean, B., Thompson, E.J., 1993. Elevated serum levels of tumor necrosis factor-α in Guillain-Barré syndrome. Ann. Neurol. 33, 591-596.
46. Street, N.E., Mosmann, T.R., 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5, 171-177.
47. Sun, J.-B., Link, H., Olsson, T., Xiao, B.-G., Andersson, G., Ekre, H.-P., Linington, C., Diener, P., 1991a. T and B cell responses to myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146, 1490-1495.
48. Sun, J.-B., Olsson, T., Wang, W.-Z., Xiao, B.-G., Kostulas, V., Fredrikson, S., Ekre, H.-P., Link, H., 1991b. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21, 1461-1468.
49. Traugott, U., Lebon, P., 1988. Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann. Neurol. 24, 243-251.
50. Voskuhl, R.R., Martin, R., Bergman, C., Dalal, M., Ruddle, N.H., McFarland, H.F., 1993. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15, 137-143.
51. Weller, M., Stevens, A., Sommer, N., Melms, A., Dichgans, J., Wiethölter, H., 1991. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J. Neurol. Sci. 104, 215-221.
52. Zhu, J., Link, H., Mix, E., Olsson, T., Huang, W.-X., 1994. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol. Scand. 90, 19-25.